Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer

By Rutqvist Lars   Johansson Hemming   Group on behalf of the Stockholm Breast Cancer Study  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 133-145

Informa Healthcare

Access to resources Recommend Favorite

Follow-up Cost of Breast Cancer Patients with Localized Disease After Primary Treatment: a Randomized Trial

By Kokko R.  

Breast Cancer Research and Treatment, Vol. 93, Iss. 3, 2005-10 ,pp. : 255-260

Springer Publishing Company

Access to resources Recommend Favorite

The ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) Trial in Postmenopausal Women with Early Breast Cancer – Updated Efficacy Results Based on a Median Follow-up of 47 Months

By Buzdar A.  

Breast Cancer Research and Treatment, Vol. 77, Iss. 3, 2003-02 ,pp. : 295-295

Springer Publishing Company

Access to resources Recommend Favorite

Breast-Conservative Surgery With and Without Radiotherapy in Patients Aged 55–75 Years With Early-Stage Breast Cancer: A Prospective, Randomized, Multicenter Trial Analysis After 108 Months of Median Follow-up

By Tinterri C.   Gatzemeier W.   Costa A.   Gentilini M.   Zanini V.   Regolo L.   Pedrazzoli C.   Rondini E.   Amanti C.   Gentile G.   Taffurelli M.   Fenaroli P.   Tondini C.   Sacchetto G.   Sismondi P.   Murgo R.   Orlandi M.   Cianchetti E.   Andreoli C.  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 408-415

Springer Publishing Company

Access to resources Recommend Favorite

Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients

By Saarto Tiina   Vehmanen Leena   Virkkunen Pekka   Blomqvist Carl  

Acta Oncologica, Vol. 43, Iss. 7, 2004-10 ,pp. : 650-656

Informa Healthcare

Access to resources Recommend Favorite